Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.2.1.7 (
BAL
)
1,977
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The phi vML3 bacteriophage
lysin
is specific for lactococci and could be used to promote enzyme release during cheese manufacture. The level of
lysin
expression from the cloned gene using its own upstream sequences is very low. Expression in Escherichia coli by using a synthetic hybrid
lysin
gene and a series of
BAL
31 deletions of the original cloned DNA fragment suggested that the start of the gene had previously been incorrectly assigned. Reevaluation of homology between the
lysin
and Bacillus subtilis PZA protein 15 led to the identification of a new potential ribosome binding site (RBS). A 0.72-kb PCR-generated fragment including this RBS and the complete
lysin
gene was expressed and inducibly controlled. The translational start of the
lysin
gene was identified as an isoleucine codon, and this may lead to a low translation rate. During the analysis of the
BAL
31 deletion fragments, two proteins of 20 and 8 kDa were shown to be expressed from the originally defined
lysin
gene. The DNA sequence has a second open reading frame with a good RBS and two potential start methionines. The smaller
lysin
protein was isolated, and the N terminus was sequenced, confirming that one methionine codon acted as the start of a second gene. The larger
lysin
protein has homology with lysozymes. The smaller
lysin
protein has some features resembling those of a holin. The possible roles of these two proteins in lysis of lactococci are discussed.
...
PMID:Controlled expression and structural organization of a Lactococcus lactis bacteriophage lysin encoded by two overlapping genes. 794 54